share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  08/17 03:23

牛牛AI助理已提取核心訊息

Pfizer Inc. (PFE) Chairman & CEO, Albert Bourla, has been reported to engage in a transaction involving the company's stock. The action, which took place on August 15, 2024, is part of the regular financial disclosures made by corporate executives. However, the details regarding the number of shares involved, the nature of the transaction, and the total value remain undisclosed. Investors are advised to monitor official filings for complete transaction details.
Pfizer Inc. (PFE) Chairman & CEO, Albert Bourla, has been reported to engage in a transaction involving the company's stock. The action, which took place on August 15, 2024, is part of the regular financial disclosures made by corporate executives. However, the details regarding the number of shares involved, the nature of the transaction, and the total value remain undisclosed. Investors are advised to monitor official filings for complete transaction details.
輝瑞製藥公司(PFE)董事長兼CEO阿爾伯特·布拉被報道參與了公司股票的交易。這一行動發生在2024年8月15日,是公司高管定期進行的財務披露的一部分。但是,有關涉及的股票數量、交易性質和總價值的細節仍未公開。投資者應監督官方文件以了解完整的交易細節。
輝瑞製藥公司(PFE)董事長兼CEO阿爾伯特·布拉被報道參與了公司股票的交易。這一行動發生在2024年8月15日,是公司高管定期進行的財務披露的一部分。但是,有關涉及的股票數量、交易性質和總價值的細節仍未公開。投資者應監督官方文件以了解完整的交易細節。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。